Nu Skin Enterprises Downgraded by Zacks to “Neutral” (NUS)
Nu Skin Enterprises (NYSE:NUS) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued on Wednesday, Stock Ratings Network reports. They currently have a $101.20 price target on the stock. Zacks‘ target price would suggest a potential upside of 3.01% from the stock’s previous close.
A number of other analysts have also recently weighed in on NUS. Analysts at Sidoti downgraded shares of Nu Skin Enterprises (NYSE:NUS) from a “buy” rating to a “neutral” rating in a research note to investors on Friday, September 27th. Separately, analysts at DA Davidson downgraded shares of Nu Skin Enterprises (NYSE:NUS) from a “buy” rating to a “neutral” rating in a research note to investors on Thursday, September 12th. They noted that the move was a valuation call. Finally, analysts at Wedbush raised their price target on shares of Nu Skin Enterprises (NYSE:NUS) from $81.00 to $103.00 in a research note to investors on Monday, August 5th. They now have an “outperform” rating on the stock. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $89.03.
Nu Skin Enterprises (NYSE:NUS) traded down 0.24% during mid-day trading on Wednesday, hitting $98.00. The stock had a trading volume of 994,449 shares. Nu Skin Enterprises has a one year low of $32.36 and a one year high of $99.60. The stock has a 50-day moving average of $90.29 and a 200-day moving average of $68.61. The company has a market cap of $5.749 billion and a P/E ratio of 24.78.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.26. The company had revenue of $682.90 million for the quarter, compared to the consensus estimate of $579.10 million. During the same quarter in the previous year, the company posted $0.94 earnings per share. The company’s revenue for the quarter was up 15.1% on a year-over-year basis. Analysts expect that Nu Skin Enterprises will post $5.15 EPS for the current fiscal year.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.